Trial Profile
A Randomized, Double-Blind, Active- and Placebo-Controlled, Single-Dummy, 4-Way Crossover Study to Determine the Abuse Potential of Pitolisant Compared to Phentermine and Placebo, in Healthy, Non-Dependent Recreational Stimulant Users
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Apr 2021
Price :
$35
*
At a glance
- Drugs Pitolisant (Primary) ; Phentermine
- Indications Hypersomnia; Narcolepsy; Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bioprojet
- 20 Nov 2019 According to a Harmony Biosciences media release, results from this study were presented World Sleep 2019 meeting.
- 20 Nov 2019 According to a Harmony Biosciences media release, results from this study were published in the Sleep.
- 16 Sep 2019 According to a Harmony Biosciences media release, data from this trial will be presented at the World Sleep 2019 meeting in Vancouver, Canada from September 20-25, 2019.